Researcher.Life Logo

Nevrologiya, Neiropsikhiatriya, Psikhosomatika : Impact Factor & More

eISSN: 2310-1342pISSN: 2074-2711
JournalOpen Access

Key Metrics

CiteScore
1.3
H-Index
11
SJR
Q4Clinical Psychology
SNIP
0.31
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Nevrologiya, Neiropsikhiatriya, Psikhosomatika

Nevrologiya, Neiropsikhiatriya, Psikhosomatika Journal Specifications

Overview
Publisher Ima-Press Publishing House
Language Russian
Publication Time6
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageRussian
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicyPreprint and postprint Policy
License typeCC BY
OA statementVisit website
View less

Planning to publish in Nevrologiya, Neiropsikhiatriya, Psikhosomatika ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Nevrologiya, Neiropsikhiatriya, Psikhosomatika

Sulpiride (Eglonil) in the treatment of somatoform and anxiety disorders. A review of the literature
  • 24 Apr 2026
  • Neurology, Neuropsychiatry, Psychosomatics
The hidden scale: the true contribution of primary progressive multiple sclerosis to overall disability statistics
  • 24 Apr 2026
  • Neurology, Neuropsychiatry, Psychosomatics
Human herpesvirus 6A and other risk factors for multiple sclerosis
  • 24 Apr 2026
  • Neurology, Neuropsychiatry, Psychosomatics
Clinical and radiological diagnostic algorithm for acute vestibular syndrome
  • 24 Apr 2026
  • Neurology, Neuropsychiatry, Psychosomatics
Title not available
  • 24 Apr 2026
  • Neurology, Neuropsychiatry, Psychosomatics
The challenges of diagnosing non-convulsive status epilepticus
  • 24 Apr 2026
  • Neurology, Neuropsychiatry, Psychosomatics
Sulpiride (Eglonil) in the treatment of somatoform and anxiety disorders. A review of the literature
  • 24 Apr 2026
  • Neurology, Neuropsychiatry, Psychosomatics
The hidden scale: the true contribution of primary progressive multiple sclerosis to overall disability statistics
  • 24 Apr 2026
  • Neurology, Neuropsychiatry, Psychosomatics
Human herpesvirus 6A and other risk factors for multiple sclerosis
  • 24 Apr 2026
  • Neurology, Neuropsychiatry, Psychosomatics
Clinical and radiological diagnostic algorithm for acute vestibular syndrome
  • 24 Apr 2026
  • Neurology, Neuropsychiatry, Psychosomatics
Title not available
  • 24 Apr 2026
  • Neurology, Neuropsychiatry, Psychosomatics
The challenges of diagnosing non-convulsive status epilepticus
  • 24 Apr 2026
  • Neurology, Neuropsychiatry, Psychosomatics

FAQs on Nevrologiya, Neiropsikhiatriya, Psikhosomatika